Description
Dialysis appointments can begin to blur together. Remembering what happened during treatment, noticing recurring concerns, and knowing what to ask at your next appointment isn’t always easy.
Renal Care Planner is a patient-owned, 90-day chairside companion designed specifically for people receiving in-center hemodialysis.
Built around a simple four-stage system — Track, Recognize, Prepare, and Participate — this practical workbook helps patients document their treatment experiences, recognize patterns over time, and bring clearer questions to their dialysis care team.
Inside the 120-page planner
- Treatment Tracking: 40 dedicated treatment entries with space to document what happened, access-related concerns, treatment information, recovery, and questions.
- Pattern Recognition: Monthly and 90-day reviews to look back at recurring experiences and concerns.
- Conversation Preparation: Structured pages to organize questions and identify topics worth discussing with the care team.
- Patient Education: Plain-language explanations of dialysis-related topics to support more informed conversations.
- Personal Reference: Space for important contacts, medications, access information, and additional notes.
The planner is intentionally flexible. Patients can write as much or as little as they need. When nothing unusual happens during treatment, simply marking “Routine” is enough.
Whether you’re beginning dialysis or have been receiving treatment for years, Renal Care Planner offers a practical way to keep your experiences organized, remember what matters, and participate more confidently in conversations about your care.
Details
- 120 pages, 8.5 × 11 in
- Color interior on uncoated paper you can write on with pen or pencil
- Coil (spiral) binding that lies flat
- Printed to order; free shipping to US addresses
This planner is a personal organizational and educational resource. It does not replace medical records, individualized medical advice, or instructions from your healthcare team.
Reviews
There are no reviews yet.